Evidence map›Paper›PMID 35520090›Full record

ArticleRSC advances2020

Polymers prepared through an "ATRP polymerization-esterification" strategy for dual temperature- and reduction-induced paclitaxel delivery.

JingWen Xu, ZhuoMiao Cui, Xin Ge, YanLing Luo, Feng Xu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

JingWen XuSchool of Food and Biological Engineering, Shaanxi University of Science and Technology Xi'an 710021 China xujingwen@sust.edu.cn.ORCID https://orcid.org/0000-0002-7055-2826
ZhuoMiao CuiKey Laboratory of Macromolecular Science of Shaanxi Province, School of Chemistry and Chemical Engineering, Shaanxi Normal University Xi'an 710062 China fengxu@snnu.edu.cn.ORCID https://orcid.org/0000-0002-9710-7722
Xin GeThe First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China Hefei Anhui 230001 China.
YanLing LuoKey Laboratory of Macromolecular Science of Shaanxi Province, School of Chemistry and Chemical Engineering, Shaanxi Normal University Xi'an 710062 China fengxu@snnu.edu.cn.ORCID https://orcid.org/0000-0003-0470-5393
Feng XuKey Laboratory of Macromolecular Science of Shaanxi Province, School of Chemistry and Chemical Engineering, Shaanxi Normal University Xi'an 710062 China fengxu@snnu.edu.cn.ORCID https://orcid.org/0000-0002-6042-6906
Institute of Macromolecular Chemistry · UAChina XD Group (China) · CNUniversity of Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinically, the nanotherapy of tumors has been limited by the drug content, efficiency of targeted release, and bioavailability. In this study, we fabricated an amphiphilic block polymer, poly(2-methacryloyloxyethyl thiocticcarboxylate)-

Identifiers

PMID35520090
PMCPMC9055954
OpenAlexW3047221513

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.